230 related articles for article (PubMed ID: 24748579)
21. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
22. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
23. Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites.
Jones KS; Redmond J; Fulford AJ; Jarjou L; Zhou B; Prentice A; Schoenmakers I
J Steroid Biochem Mol Biol; 2017 Sep; 172():130-135. PubMed ID: 28732681
[TBL] [Abstract][Full Text] [Related]
24. Serum vitamin D, vitamin D binding protein, and lung cancer survival.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734
[TBL] [Abstract][Full Text] [Related]
25. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.
Zhang SM; Willett WC; Selhub J; Hunter DJ; Giovannucci EL; Holmes MD; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2003 Mar; 95(5):373-80. PubMed ID: 12618502
[TBL] [Abstract][Full Text] [Related]
26. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
28. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women.
Sinotte M; Diorio C; Bérubé S; Pollak M; Brisson J
Am J Clin Nutr; 2009 Feb; 89(2):634-40. PubMed ID: 19116321
[TBL] [Abstract][Full Text] [Related]
30. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
31. Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D.
Johnsen MS; Grimnes G; Figenschau Y; Torjesen PA; Almås B; Jorde R
Scand J Clin Lab Invest; 2014 Apr; 74(3):177-83. PubMed ID: 24383929
[TBL] [Abstract][Full Text] [Related]
32. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
34. Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II.
Kotsopoulos J; McGee EE; Lozano-Esparza S; Garber JE; Ligibel J; Collins LC; Polyak K; Brown M; Narod S; Tamimi RM; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1264-1270. PubMed ID: 32277005
[TBL] [Abstract][Full Text] [Related]
35. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
Kühn T; Kaaks R; Becker S; Eomois PP; Clavel-Chapelon F; Kvaskoff M; Dossus L; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Lukanova A; Buijsse B; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Krogh V; Sacerdote C; Tumino R; Mattiello A; Buckland G; Sánchez MJ; Menéndez V; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; van Duijnhoven FJ; van Gils CH; Bakker MF; Weiderpass E; Skeie G; Brustad M; Andersson A; Sund M; Wareham N; Khaw KT; Travis RC; Schmidt JA; Rinaldi S; Romieu I; Gallo V; Murphy N; Riboli E; Linseisen J
Int J Cancer; 2013 Oct; 133(7):1689-700. PubMed ID: 23526380
[TBL] [Abstract][Full Text] [Related]
36. Association of blood lead level with vitamin D binding protein, total and free 25-hydroxyvitamin D levels in middle-school children.
Rahman A; Al-Sabah R; Jallad R; Rao MS
Br J Nutr; 2022 Apr; 127(7):982-992. PubMed ID: 34078483
[TBL] [Abstract][Full Text] [Related]
37. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
Eliassen AH; Tworoger SS; Mantzoros CS; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):161-4. PubMed ID: 17220346
[TBL] [Abstract][Full Text] [Related]
38. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
39. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
40. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer.
Bertone-Johnson ER; Chen WY; Holick MF; Hollis BW; Colditz GA; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1991-7. PubMed ID: 16103450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
